Cargando…
Evaluation at scale of microbiome-derived metabolites as biomarker of flavan-3-ol intake in epidemiological studies
The accurate assessment of dietary intake is crucial to investigate the effect of diet on health. Currently used methods, relying on self-reporting and food composition data, are known to have limitations and might not be suitable to estimate the intake of many bioactive food components. An alternat...
Autores principales: | Ottaviani, Javier I., Fong, Redmond, Kimball, Jennifer, Ensunsa, Jodi L., Britten, Abigail, Lucarelli, Debora, Luben, Robert, Grace, Philip B., Mawson, Deborah H., Tym, Amy, Wierzbicki, Antonia, Khaw, Kay-Tee, Schroeter, Hagen, Kuhnle, Gunter G. C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6026136/ https://www.ncbi.nlm.nih.gov/pubmed/29959422 http://dx.doi.org/10.1038/s41598-018-28333-w |
Ejemplares similares
-
Evaluation of (−)-epicatechin metabolites as recovery biomarker of dietary flavan-3-ol intake
por: Ottaviani, Javier I., et al.
Publicado: (2019) -
Biomarker-estimated flavan-3-ol intake is associated with lower blood pressure in cross-sectional analysis in EPIC Norfolk
por: Ottaviani, Javier I., et al.
Publicado: (2020) -
Associations between flavan-3-ol intake and CVD risk in the Norfolk cohort of the European Prospective Investigation into Cancer (EPIC-Norfolk)
por: Vogiatzoglou, Anna, et al.
Publicado: (2015) -
Enantioselctive Syntheses of Sulfur Analogues of Flavan-3-Ols
por: Sharma, Pradeep K., et al.
Publicado: (2010) -
Flavan-3-ols and Cardiometabolic Health: First Ever Dietary Bioactive Guideline
por: Crowe-White, Kristi M, et al.
Publicado: (2022)